CPT 2027 Code Set: What Molecular Labs Should Check Before January 1
Short answer: The AMA released the CPT 2027 code set on September 9, 2026, with 453 editorial changes effective January 1. For molecular labs, the work is not reading the whole set but checking which codes touch your menu, then tracking PLA publication dates, CMS pricing updates, and payer prior authorization lists separately.
Every autumn, the CPT code set turns over, and every autumn some molecular lab discovers in January that a code on its test menu changed, was deleted, or landed on a payer edit list it never saw. The AMA's release for CPT 2027 is a good prompt to build a repeatable process. This article walks through what the AMA actually announced, what it did not say about laboratory codes, how the separate Proprietary Laboratory Analyses (PLA) calendar works, and how a payer notice from earlier this year shows the lead times labs are really working with. It is written for lab operations, revenue cycle, and compliance teams, not for ordering clinicians or patients.
What the AMA announced for CPT 2027
According to the AMA's September 9, 2026 press release, the CPT 2027 code set contains 453 editorial changes: 299 additions, 74 revisions, and 80 deletions. The release also reports 10 new AI-related codes, bringing the total number of AI-related codes to 43. The updates take effect January 1, and Healthcare Finance News reports the effective year as 2027.
The clinical areas Healthcare Finance News highlights from the release include maternity care, ventricular assist device procedures, hernia repair, prostate biopsy, biofeedback, radiology, and sleep medicine. Notably, neither the AMA release nor that coverage mentions genomic or laboratory codes in its highlights. That does not mean the set contains no lab changes; it means the headline summaries do not tell a molecular lab whether its codes are affected. The only way to know is to compare your own code list against the full code set when you have it.
That gap is the first lesson: press-release summaries are written for the broad physician audience. A lab that waits for a headline about molecular pathology will be waiting a long time. Treat the annual release as a trigger to run your own code audit, not as a source of conclusions.
Why 80 deletions matter more than 299 additions
New codes get attention, but deletions are where claims break. A deleted code on a claim with a 2027 date of service is a straightforward rejection or denial. The practical risk sits in the places where codes are hard-coded: test directories, LIS-to-billing interfaces, chargemasters, client price lists, and payer-specific billing rules. A lab with several hundred test-to-code mappings will not catch a deletion by eyeballing a spreadsheet in December.
A workable approach is to export your active test menu with every billed code, including unlisted codes and PLA codes, and match it against the deletion and revision lists as soon as they are accessible to you. If your menu leans on unlisted codes, read our guide to CPT 81479 unlisted molecular code denials first, because a code revision can change whether an unlisted code is still the right choice at all.
The PLA calendar runs on its own clock
PLA codes are alphanumeric CPT codes that let laboratories or manufacturers identify specific tests, including advanced diagnostic laboratory tests (ADLTs) and FDA-cleared or approved clinical diagnostic laboratory tests. The AMA notes they were created following a 2016 CMS final rule under the Protecting Access to Medicare Act (PAMA). They are released quarterly, and per the AMA, new codes are effective in the quarter following their publication.
The AMA's PLA calendar lists the following publication and effective dates, which it notes are subject to change:
The consequence is that a PLA code can be public for up to a quarter before it is effective, and an annual CPT release in September does not capture codes published later in the cycle. A lab that only reviews codes once a year will always be a few months behind. For the application side of this process, see our article on the PLA code application deadline for 2027.
The AMA also states eligibility limits that matter for strategy: the test must be commercially available when the application is submitted, tests with a physician work component are not eligible, and algorithm-only analyses of existing results without biomarker analysis are not eligible. A lab planning a new menu item should check those boundaries before assuming a PLA code will exist.
Code publication is not payment or coverage
Getting a code is the beginning of the process, not the end. CMS Change Request 14569, the October 2026 quarterly update to the Clinical Laboratory Fee Schedule and CLIA HCPCS codes, carries an effective date of October 1, 2026 and an implementation date of October 5, 2026. It states that new PLA codes are priced by the Medicare Administrative Contractor where applicable until they are nationally priced. It also reminds labs to confirm CLIA certification for codes marked as not waived, and to use the QW modifier when a lab holds only a certificate of waiver or provider-performed microscopy certificate. For a fuller read of that update, see our October 2026 CLFS quarterly update article.
Even a nationally recognized code can then land on a commercial payer's edit list. In a notice dated June 15, 2026, UnitedHealthcare announced that, beginning October 1, 2026, codes 0648U and 0651U would be added to its genetic and molecular prior authorization requirements across several plan types, including its exchange plans. The notice states that without prior authorization requested before the date of service, UnitedHealthcare will deny the claim and the provider cannot balance bill the member.
The 108 days between the notice and the effective date is a useful planning benchmark, though it is one example from one payer and should not be read as a universal rule. The point is that payer notices are published on payer timelines, not the AMA's. For the broader picture, read our analysis of UnitedHealthcare's genetic testing prior authorization policy.
A year-end checklist for molecular labs
The following sequence keeps the work manageable and assigns it to the right owners. Start by exporting every billed code from the LIS and chargemaster, including PLA, Tier 2, and unlisted codes. Compare it against the CPT 2027 deletions and revisions once your team has access to the full set. Flag any test whose code changes, and have a coder confirm the replacement and any changed descriptor language rather than assuming a one-to-one swap.
Next, subscribe to every payer's provider news feed that matters to your volume and set a recurring review of their genetic and molecular prior authorization lists. Track CMS quarterly CLFS updates and MolDX or MAC notices for pricing and coverage status of the codes you bill. Finally, build the dates into a shared calendar: the AMA PLA publication and effective dates, CMS implementation dates, and each payer's stated effective dates. A claim that meets all three conditions on the date of service is far more likely to be paid.
Labs should also keep an eye on the policy fight over the code set itself. The Healthcare Finance News report notes that CMS accepted comments through September 14 on alternatives to the national physician-services coding standard. We covered that issue in our article on the CPT code set challenge. Nothing in the material reviewed here changes the January 1 effective date, so labs should plan on the CPT 2027 set being the working standard.
Frequently asked questions
When does the CPT 2027 code set take effect?
The AMA states that the updates take effect January 1, and Healthcare Finance News reports the year as 2027. Claims are generally coded by date of service, so a lab should have updated code mappings tested in its billing system well before that date to avoid rejections in the first weeks of January.
Does CPT 2027 include new genomic or molecular codes?
The AMA press release highlights areas such as prostate biopsy and radiology and does not mention genomic or laboratory codes in its summary. That is not proof that none exist. A lab should review the full code set against its own test menu rather than relying on press summaries.
How are PLA codes different from the annual CPT update?
PLA codes are published quarterly, and the AMA says new codes are effective in the quarter following publication. Under the AMA calendar, the Fall 2026 cycle publishes January 1, 2027 and becomes effective April 1, 2027. The annual set only reflects codes published by its cutoff, so labs must track both.
Does a new code mean payers will cover the test?
No. A code identifies a test; it does not create coverage or a payment rate. CMS states that new PLA codes are priced by the Medicare Administrative Contractor where applicable until nationally priced, and commercial payers set their own policies. UnitedHealthcare's October 1, 2026 prior authorization addition of 0648U and 0651U shows payers act on their own schedules.
What should a lab do first?
Export every billed code from the LIS and chargemaster and match it against the deleted and revised code lists. Deleted codes cause the most predictable claim failures. Then assign owners for payer notice monitoring, CMS quarterly updates, and the PLA calendar so that each date is tracked by a named person.
See how ScreenMyGene supports lab coverage and coding decision support.
This article is for educational purposes only and is B2B decision support for laboratories and their revenue cycle teams. It is not legal, coding, billing, or medical advice. Verify code changes, payer policies, and coverage rules against the original sources before acting.
Sources: AMA, "AMA releases CPT 2027 code set" (Sept. 9, 2026), ama-assn.org; Healthcare Finance News, "New AMA CPT codes reflect medical innovation and AI-related services"; AMA, CPT PLA codes page and CPT PLA calendar, ama-assn.org; CMS Change Request 14569, October 2026 CLFS and CLIA HCPCS codes update, cms.gov; UnitedHealthcare Provider News, "New AMA codes: genetic and molecular PA requirements" (June 15, 2026), uhcprovider.com.